期刊文献+

急性生理和慢性健康状况评价系统Ⅱ在心血管急重症患者中的应用评价 被引量:5

Clinical application of acute physiology and chronic health evaluation Ⅱ in cardiac critical care patients
下载PDF
导出
摘要 目的评估急性生理和慢性健康状况评价系统Ⅱ(APACHEⅡ)在心血管急重症患者临床评价中的作用。方法连续入选345例心血管急重症住院患者,进行APACHEⅡ评分,同时检测N末端脑钠肽前体(NT-proBNP)、大内皮素等临床相关指标,比较患者院内的预期病死率和实际病死率。结果 345例患者的实际病死率和预期病死率分别为4.93%和7.85%(P>0.05)。受试者工作特征曲线下面积为0.832。单因素回归分析显示,APACHEⅡ评分参数———呼吸频率(OR=1.17,95%CI:1.04~1.31,P=0.01)、血钠浓度(OR=0.90,95%CI:0.81~0.99,P=0.03)、血肌酐浓度(OR=1.01,95%CI:1.00~1.02,P<0.01)、白细胞计数(OR=1.18,95%CI:1.05~1.33,P<0.01)与死亡率相关,而非APACHEⅡ评分因素———总蛋白(OR=0.95,95%CI:0.90~0.99,P=0.04)、白蛋白(OR=0.90,95%CI:0.83~0.99,P=0.02)、谷草转氨酶(OR=1.00,95%CI:1.00~1.01,P<0.01)、谷丙转氨酶(OR=1.00,95%CI:1.00~1.001,P=0.01)、NT-proBNP(OR=1.00,95%CI:1.00~1.01,P=0.02)、大内皮素(OR=1.58,95%CI:1.02~2.45,P=0.01)、是否进行机械通气(OR=178.36,95%CI:19.75~1610.72,P<0.01)亦与病死率相关。多因素回归分析表明,钠值(OR=0.846,95%CI:0.740~0.968,P=0.015)、机械通气(OR=358.7,95%CI:27.2~4731.7,P<0.01)与病死率相关。结论 APACHEⅡ模型对心血管急重症患者的预后有一定的判断作用,但仍有很多不足之处。 Objective To evaluate the use of acute physiology and chronic health evaluation (APACHEⅡ ) in cardiac critical care patients and analyze its deficiencies. Methods A retrospective study was performed in 345 patients admitted to ICU from December 1, 2009 to April 31, 2010. APACHE Ⅱ score was calculated. Expected and actual in-hospital mortality rate was compared. Results The actual death rate was 4. 93% ( n = 17 ), the predicted death rate was 7.85% , and there was no significant difference between them ( P 〉 0. 05 ). Univariate regression analysis showed that, for the acute physiology parameters, respiratory rate ( OR = 1.17, 95% CI: 1.04-1.31, P =0.01 ) , Na ( OR =0. 9, 95% CI: 0. 81- 0.99, P=0.03), Cr (OR=1.01, 95% CI: 1.00-1.02, P〈0.01), WBC (OR=I. 18, 95%CI: 1.05- 1.33, P 〈0. 01 ) were correlated with death. For other commonly used parameters, total protein ( OR = 0.95, 95%CI: 0.90-0.99, P =0.04), ALB (OR=0.90, 95% CI- 0.83-0.99, P=0.02), AST (OR= 1.00, 95%CI: 1.00-1.01, P〈0.01), ALT (OR=l.00, 95%CI: 1.00-1.001, P=O. 01), NT-proBNP (OR= 1.00, 95% CI: 1.00-1.01, P=0.02), Big-ET (OR=1.58, 95%CI: 1.02-2.45, P=0.01),Mechanical Ventilation (OR = 178.36, 95% CI: 19.75-1610. 72, P 〈 0. 01 ) were correlated with death. And the multivariate regression analysis showed that Na ( OR = 0. 846, 95% CI: 0. 74-0. 968, P = 0. 015 ) and Mechanical Ventilation ( OR =358. 7, 95% CI: 27.2-4 731.7, P 〈0. 01 ) were correlated with death. Conclusions APACHE lI has a certain effect on the prediction of prognosis of cardiac critical care patients, but it has some deficiencies.
出处 《中国心血管杂志》 2013年第2期97-99,共3页 Chinese Journal of Cardiovascular Medicine
关键词 急性生理和慢性健康状况评价系统Ⅱ 重症监护 预后 Acute physiology and chronic health evaluation Ⅱ Intensive care Prognosis
  • 相关文献

参考文献4

  • 1Dragsted L, Jorgensen J, Jensen NH, et al. Interhospitalcomparisons of patient outcome from intensive care : importance oflead-time bias. Crit Care Med, 1989 ,17 :418-422.
  • 2Colpan A,Akinci E, Erbay A, et al. Evaluation of risk factorsfor mortality in intensive care units : a prospective study from areferral hospital in Turkey. Am J Infect Control, 2005,33:42-47.
  • 3张健,韦丙奇,徐慧聪,黄初林,张宇辉,王东,杨跃进,高润霖.多器官病变在心力衰竭死亡患者中的发生状况和趋势[J].中华医学杂志,2010,90(46):3264-3267. 被引量:8
  • 4Cerra FB, Negro F,Abrams J. APACHE D score does notpredict multiple organ failure or mortality in postoperative surgicalpatients. Arch Surg, 1990,125 :519-522.

二级参考文献14

  • 1王今达,王宝恩.多脏器功能失常综合征(MODS)病情分期诊断及严重程度评分标准(经庐山’95全国危重病急救医学学术会讨论通过)[J].中国危重病急救医学,1995,7(6):346-347. 被引量:1415
  • 2Abraham WT,Fonarow GC,Albert NM,et al.Predictors of inhospital mortality in patients hospitalized for heart failure:insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).J Am Coil Cardio1,2008,52:347-356.
  • 3Fonarow GC,Peacock WF,Phillips CO,et al.Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure.J Am Coil Cardiol,2007,49:1943-1950.
  • 4Nicol ED,Fittall B,Roughton M,et al.NHS heart failure survey:a survey of acute heart failure admission in England,Wales and Northern Ireland.Heart,2008,92:172-177.
  • 5Dickstein K,Cohen-Solal A,Filippatos G,et al.ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008:the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology.Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM).Eur Heart J,2008,29:2388-2442.
  • 6Jessup M,Abraham WT,Casey DE,et al.2009 focused update:ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults:a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines:developed in collaboration with the International Society for Heart and Lung Transplantation.Circulation,2009,119:1977-2016.
  • 7Koelling TM,Chen RS,Lubwama RN,et al.The expandingnational burden of heart failure in the United States:the influence of heart failure in women.Am Heart.J,2004,147:74-78.
  • 8Young JB,Abraham WT,Albert NM,et al.Relation of low hemoglobin and anemia to morbidity and mortality in patients hospitalized with heart failure (insight from the OPTIMIZIE-HF Registry).Am J Cardiol,2008,101,223-230.
  • 9Zimmerman JE,Khaus WA,Sun X,et al.Severity stratification and outcome prediction for multisystem organ failure and dysfunction.World J Surg,1996,20:401-405.
  • 10Forman DE,Butler J,Wang Y,et al.Incidence,predictors at admission,and impact of worsening renal function among patients hospitalized with heart failure.J Am Coll Cardiol,2004,43:61-67.

共引文献7

同被引文献29

  • 1刘梅林,李继敏,胡大一,马志敏,高霖,庞永正.心绞痛患者血浆N-proBNP水平的变化及其临床意义[J].中华心血管病杂志,2004,32(6):497-500. 被引量:66
  • 2梁建业.危重病患者病情评定法——APACHE系统的研究进展[J].中国危重病急救医学,1996,8(1):52-56. 被引量:65
  • 3MARTINEZ-RUMAYOR A, RICHARDS A M, BURNETT J C, et al. Biology of the natriuretic pep- tides[J]. Am J Cardio, 2008,101 : 3- 81.
  • 4MARK R,RICHARD W. NT-proBNP in heart failure therapy decisions and rnonitoring[J]. The Eur J Heart Fail,2004,6:351-351.
  • 5Tonelli M,Sacks F. Relation between red blood cell dis-tribution width and cardiovascular event rate in peoplewith coronary disease[ J] . Circulation ,2008,117 (2) :163-168.
  • 6Felker GM,Allen LA . Red cell distribution width as anovel prognostic marker in heart failure : data from theCHARM Program and the Duke Databank[ J]. J Am Coil-Cardiol,2007,50(l) :4047.
  • 7Dabbah S,Hammerman H. Relation between red cell dis-tribution width and chinical outcomes after actue myocar-dial infarction[ J] . Am J Cardiol ,2010,105(3) ,312 -317.
  • 8Kalantar - Zadeh K. Nutritional and anti - inflammatoryinterventions in chronic heart failure [ J ]. Am J Cardiol,2008,101(6):89-103.
  • 9Cotter G, Felker GM. The pathophysiology of actue heartfailure - is all about fluid accumulation [ J ]. Am Heart J,2008,155(3):9-18.
  • 10Oh J. Prognostic value of change in red cell distributionwidth 1 month after discharge in acute decompensated heartfailure patients[J]. Circ J, 2013,76(20) :109 -116.

引证文献5

二级引证文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部